Your session is about to expire
← Back to Search
Cell Therapy
HLA-Identical Sibling Renal Transplant Tolerance
N/A
Waitlist Available
Led By Joshua Miller, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Summary
This trial is testing whether donor stem cells can be used to stop a recipient's body from rejecting a transplanted kidney from the same donor, without the use of immunosuppressive drugs.
Eligible Conditions
- Kidney Transplant
- Immunosuppression
- Transplant Rejection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
No separate arms: All Enrolled Receive Same Treatment
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,649 Previous Clinical Trials
958,541 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,455 Previous Clinical Trials
4,334,878 Total Patients Enrolled
Joshua Miller, MDPrincipal InvestigatorNorthwestern University